In a significant victory for reproductive rights advocates, the US Supreme Court has issued a ruling that upholds women's access to mifepristone, a key component in the medication abortion process. The court's decision effectively blocks lower-court restrictions on the drug, which would have severely limited its availability. The move comes as a lawsuit challenging the FDA's approval of mifepristone continues to wind its way through the judicial system. Women's health advocates are hailing the ruling as a crucial step in protecting access to safe and effective abortion care, while opponents of abortion rights have vowed to continue their fight to restrict access to the drug.
The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
